Harbour BioMed and Kelun-Biotech have received approval from China’s National Medical Products Administration to b...
Kelun-Biotech has received approval from the Center for Drug Evaluation of China’s National Medical Products Admin...
How would you assess the current state of Thailand's life sciences ecosystem, and what key developments have stood out o...
The Singapore Clinical Research Institute (SCRI) convened its Clinical Trials Symposium 2026 on 30th July, bringing toge...
BioLineRx and Hemispherian will present preclinical data on GLIX1 at the 2026 European Society for Medical Oncology Annu...
Akeso has launched a Phase II clinical study in the United States evaluating a cadonilimab-based combination regimen for...
HUYABIO International has reported statistically significant and clinically meaningful topline Phase 3 results for HBI-8...
Insmed has reported positive 12-month data from the ongoing open-label extension study of treprostinil palmitil inhalati...
Maxona Pharmaceuticals has received U.S. FDA clearance of its Investigational New Drug application for a Phase 2 clinica...
Lakewood-Amedex Biotherapeutics has announced preclinical safety data supporting clinical dose selection for its upcomin...
As BioSpectrum Asia reports on the ground from BIO Asia–Taiwan 2026, being held from July 15–19 in T...
Lynk Pharmaceuticals has completed patient enrolment in its Phase III clinical trial of zemprocitinib capsules for activ...
Kelun-Biotech has reported positive Phase III results for sacituzumab tirumotecan, also known as sac-TMT or SKB264/MK-28...
Lynk Pharmaceuticals has dosed the first patient in a Phase II clinical trial of LNK01004 ointment for vitiligo. The tr...
MEDIPOST has treated the first U.S. participant in its Phase III clinical trial evaluating an investigational mesenchyma...
Delonix Bioworks has dosed the first participant in its Phase 1 clinical trial of DX-104, a next-generation Group B meni...
Cell Therapies is pleased to support the launch of the CARTiEr E312 Phase I/Ib clinical trial in Australia, evaluating A...
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, has anno...
FibroBiologics has completed manufacturing of the third batch of CYWC628 drug product for its ongoing Phase 1/2 clinical...
Insilico Medicine has initiated a Phase III clinical trial of rentosertib, its AI-discovered oral small-molecule TNIK in...
Brii Biosciences has reported topline end-of-treatment data from its ongoing Phase 2b ENRICH and ENHANCE studies evaluat...
Ascletis Pharma has submitted two Investigational New Drug applications to the U.S. FDA for obesity treatment candidates...
Viking Therapeutics has initiated a Phase 1 clinical study of VK3019, an investigational dual amylin and calcitonin rece...
NeuroSense Therapeutics has reported positive biomarker findings from its Phase 2 RoAD proof-of-concept study of PrimeC ...
Innovative Molecules has dosed the first patient in its Phase 2a clinical trial evaluating adibelivir for recurrent geni...
